United States Automated Microbiology Market expected to grow at a CAGR of 9.1% during 2024-2031 | Major Compnies 2026 - Becton Dickinson and Company, Microbiology International, Thermo Fisher Scientific Inc.

Leander, Texas and Tokyo, Japan - Jan.08.2026
As per DataM intelligence research report" The Global Automated Microbiology Market is estimated to reach high CAGR 9.1% during the forecast period (2024-2031)." Laboratory automation and faster pathogen detection needs are boosting market growth.

Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/automated-microbiology-market?prasad

United States Recent Industry Developments

✅ In November 2025, Becton Dickinson (BD) launched the "Kiestra 3.0" total lab automation system The modular track connects inoculation, incubation, and imaging for a hands-off workflow It addresses the shortage of microbiology technicians in U.S. hospitals

✅ In October 2025, Thermo Fisher Scientific introduced an AI-powered colony counter The software automatically detects and enumerates bacterial growth on agar plates It speeds up turnaround times for critical infection diagnoses in the U.S.

✅ In September 2025, bioMérieux received FDA clearance for a rapid automated sterility test The system detects contaminants in cell therapy products in days rather than weeks It accelerates the release of life-saving biological drugs in the U.S.

✅ In August 2025, A U.S. diagnostics startup released a robotic sample processor for molecular microbiology The robot automates the extraction of DNA from difficult samples like stool It improves the consistency of microbiome testing in U.S. labs

Japan Recent Industry Developments

✅ In December 2025, Sysmex Corporation launched a fully automated urinalysis line with bacteria detection The system integrates flow cytometry to identify bacteria species in minutes It improves the rapid diagnosis of UTIs in Japanese clinics

✅ In November 2025, Eiken Chemical introduced a compact automated loop-mediated isothermal amplification (LAMP) system The device detects pathogens like TB and Mycoplasma with high sensitivity It brings molecular accuracy to smaller Japanese hospitals without PCR labs

✅ In October 2025, Shimadzu Corporation released a mass spectrometry platform for microbial identification The system uses AI to match protein fingerprints against a vast database It supports the precise identification of rare pathogens in Japan

✅ In September 2025, Hitachi High-Tech developed a robotic arm for handling hazardous microbiology samples The robot processes infectious samples inside a biosafety cabinet to protect staff It enhances laboratory safety standards in Japan

Automated Microbiology Market: Drivers
The automated microbiology market is expanding due to rising demand for faster diagnostics. Automation improves laboratory efficiency and accuracy. Increasing infection rates drive diagnostic testing. Technological advancements enable high-throughput analysis. Expansion of clinical laboratories supports adoption. Regulatory approvals enhance confidence.

Market growth is reinforced by integration with digital lab systems. Emerging markets invest in diagnostic infrastructure. AI-assisted analysis improves workflow efficiency. Partnerships with hospitals accelerate adoption. Focus on antimicrobial resistance boosts demand. Automated microbiology enhances clinical decision-making.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/automated-microbiology-market?prasad

Automated Microbiology Market: Major Players
Becton Dickinson and Company, Microbiology International, Thermo Fisher Scientific, Inc., bioMérieux, Inc., Cardinal Health, Beckman Coulter, Inc., Merck KGaA, Rapid Micro Biosystems, Inc., Clever Culture Systems and Zhuhai Meihua Medical Technology Ltd.

Segment Covered in the Automated Microbiology Market:
By Product
The market is segmented into instruments 30%, automated culture systems 25%, microbiology analyzers 25%, and reagents 20%. Instruments dominate due to high demand for precise, high-throughput microbiological testing in clinical and research laboratories. Automated culture systems and analyzers are growing rapidly with increasing adoption in clinical diagnostics and pharmaceutical R&D. Reagents are essential for supporting automated workflows and ensuring reliable results.

By Diagnostic Technology
Based on diagnostic technology, the market includes DNA & RNA probe technology 25%, DNA sequencing 20%, detection techniques 15%, monoclonal antibodies 15%, non-isotopic methods 10%, radioactive methods 5%, and immunoassays 10%. DNA & RNA probe technology leads due to its speed, specificity, and use in pathogen detection and microbial identification. DNA sequencing and detection techniques are growing with genomic advancements and precision microbiology applications.

By End-User
End-users include pharmaceutical & biotechnology companies 40%, clinical laboratories 45%, and others 15%. Clinical laboratories dominate due to routine diagnostic testing, infectious disease monitoring, and hospital-based microbiology workflows. Pharmaceutical and biotech companies are growing adopters for drug development, microbial testing, and quality control.

Regional Analysis
North America - 35% Share
North America leads with 35% share driven by advanced healthcare infrastructure, high adoption of automated diagnostic solutions, and increasing demand for rapid microbial detection in hospitals and laboratories.

Europe - 25% Share
Europe accounts for 25% share supported by stringent regulatory standards, rising adoption of automated microbiology workflows, and research & development activities in Germany, the UK, and France.

Asia Pacific - 25% Share
Asia Pacific holds 25% share with growing clinical laboratory networks, increasing pharmaceutical R&D, and rising awareness of infectious disease diagnostics in China, India, and Japan.

Latin America - 8% Share
Latin America represents 8% share driven by adoption of automated diagnostic systems in hospitals and laboratories, particularly in Brazil and Mexico.

Middle East & Africa - 7% Share
Middle East & Africa accounts for 7% share, supported by investments in healthcare infrastructure and modernization of clinical diagnostic laboratories in the UAE, Saudi Arabia, and South Africa.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=automated-microbiology-market

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?prasad

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.